Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Douglas Coghlan"'
Autor:
Chris Karapetis, Samuel A. L. Hall, Kate Muller, Douglas Coghlan, Mohammad A. Chinnaratha, Mahsa Tantiongco, Richard J. Woodman, Abdul Shaikh, Kailin Teh, Alan Wigg
Publikováno v:
Internal Medicine Journal. 48:936-943
Background International guidelines recommend screening for hepatitis B virus (HBV) infection prior to administration of rituximab, due to high risk of HBV reactivation in at-risk patients. Aims To determine: (i) adherence to the South Australian (SA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7bc4efa84a821d07eae4b68a40d5222
https://doi.org/10.1111/imj.13740
https://doi.org/10.1111/imj.13740
Autor:
Narelle M. Berry, Vincent L. Versace, Bogda Koczwara, Robyn Clark, David Roder, John Atherton, Shahid Ullah, Douglas Coghlan, Alexandra L. McCarthy, Julie Franzon
Aim: The link between chemotherapy treatment and cardiotoxicity is well established, particularly for adults with blood cancers. However, it is less clear for children. This analysis aimed to compare the trajectory and mortality of children and adult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08ea30396609c18081227ac2984c1305
https://hdl.handle.net/11541.2/128807
https://hdl.handle.net/11541.2/128807
Autor:
Samuel A L, Hall, Abdul, Shaikh, Kailin, Teh, Mahsa, Tantiongco, Douglas, Coghlan, Chris S, Karapetis, Mohammad A, Chinnaratha, Richard, Woodman, Kate R, Muller, Alan J, Wigg
Publikováno v:
Internal medicine journal. 48(8)
International guidelines recommend screening for hepatitis B virus (HBV) infection prior to administration of rituximab, due to high risk of HBV reactivation in at-risk patients.To determine: (i) adherence to the South Australian (SA) protocol for HB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ff01511b7638e6e8d4f9c036da87f291
https://pubmed.ncbi.nlm.nih.gov/29345413
https://pubmed.ncbi.nlm.nih.gov/29345413
Autor:
Vincent L. Versace, Alexandra L. McCarthy, Bogda Koczwara, John Atherton, Shahid Ullah, Robyn Clark, David Roder, Narelle M. Berry, Douglas Coghlan, Munir H. Chowdhury
Publikováno v:
Circulation. 133
Introduction: The causal link between chemotherapy treatments and subsequent cardiotoxicity is well established, particularly for children with hematological malignancies. Little information exists on the characteristics and outcomes for patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0868d7dad926715941d1e391fc8cb1ef
https://doi.org/10.1161/circ.133.suppl_1.mp33
https://doi.org/10.1161/circ.133.suppl_1.mp33
Publikováno v:
Internal Medicine Journal. 31:438-440
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1ffc5cfe3902428650c0dd751cb5391
https://doi.org/10.1046/j.1445-5994.2001.00085.x
https://doi.org/10.1046/j.1445-5994.2001.00085.x
Autor:
Lay Tay, Douglas Coghlan, John V. Lloyd, Ferenz Szabo, Wilfred Jaksic, Deepak Singhal, Reem Al-Qunfoidi, Elizabeth J. Duncan, Simon McRae
Publikováno v:
Seminars in thrombosis and hemostasis. 35(8)
Acquired hemophilia A (AH) is a rare and serious acquired bleeding disorder where prompt and correct diagnosis is crucial, and immune suppression is often required for factor VIII (FVIII) autoantibody eradication. The acquired FVIII deficiency usuall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e69fbc6240d622d9fd5fa5a5fbe2e7e8
https://pubmed.ncbi.nlm.nih.gov/20169513
https://pubmed.ncbi.nlm.nih.gov/20169513
Autor:
Chris Ward, Emma Perrin, Mark P Smith, Alessandra Bianchi, Douglas Coghlan, Murray J. Adams, J. Thom
Publikováno v:
Seminars in thrombosis and hemostasis. 33(3)
Technology in hemostasis laboratories has evolved enormously during the last 30 years. Although many scientists and clinicians will remember the traditional tilt-tube techniques to screen for coagulation abnormalities and to monitor anticoagulant the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34a6c444efc7f001315e10d57b1cdfb4
https://pubmed.ncbi.nlm.nih.gov/17427056
https://pubmed.ncbi.nlm.nih.gov/17427056
Autor:
Timothy To, Douglas Coghlan
Publikováno v:
Internal Medicine Journal. 38:143-144
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef08c16c255439b40d7635c966a67c2c
https://doi.org/10.1111/j.1445-5994.2007.01605.x
https://doi.org/10.1111/j.1445-5994.2007.01605.x
Publikováno v:
Journal of Thrombosis and Haemostasis. 3:2589-2590
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5223bc73b248841c6fefba304cb864da
https://doi.org/10.1111/j.1538-7836.2005.01611.x
https://doi.org/10.1111/j.1538-7836.2005.01611.x
Publikováno v:
Flinders University PURE
Objective To assess clinical usefulness of CoaguChek S and XS monitors to measure International Normalised Ratio (INR) when starting warfarin in community patients. Methods INR in consecutive patients starting warfarin plus enoxaparin was measured in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e011d61e47333474cea16aa9ffab5fd
https://researchnow.flinders.edu.au/en/publications/a8ad9ac0-8c88-4f10-88ad-c1bb7c33db6b
https://researchnow.flinders.edu.au/en/publications/a8ad9ac0-8c88-4f10-88ad-c1bb7c33db6b